Other disorders involving the immune mechanism, not elsewhere classified
Notes: Benign hypergammaglobulinemic purpura ; Polyclonal gammopathy NOS ; Cryoglobulinemic purpura ; Cryoglobulinemic vasculitis ; Essential cryoglobulinemia ; Idiopathic cryoglobulinemia ; Mixed cryoglobulinemia ; Primary cryoglobulinemia ; Secondary cryoglobulinemia ; Immune reconstitution inflammatory syndrome [IRIS] ; Mast cell activation disorder, unspecified ; Mast cell activation syndrome, NOS ; Secondary mast cell activation syndrome ; Other mast cell activation syndrome ; Immune disease NOS ; code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) ; code, if applicable, for: ; allergy status, other than to drugs and biological substances (Z91.0-) ; personal history of anaphylaxis (Z87.892) ; code to identify associated manifestations, such as: ; desquamative dermatitis (L30.8) ; diarrhea (R19.7) ; elevated bilirubin (R17) ; hair loss (L65.9) ; code to identify associated manifestations ; hyperglobulinemia NOS (R77.1) ; monoclonal gammopathy (of undetermined significance) (D47.2) ; aggressive systemic mastocytosis (C96.21) ; congenital cutaneous mastocytosis (Q82.2) ; (non-congenital) cutaneous mastocytosis (D47.01) ; (indolent) systemic mastocytosis (D47.02) ; malignant mast cell neoplasm (C96.2-) ; malignant mastocytoma (C96.29) ; mast cell leukemia (C94.3-) ; mast cell sarcoma (C96.22) ; mastocytoma NOS (D47.09) ; other mast cell neoplasms of uncertain behavior (D47.09) ; systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02) ; human immunodeficiency virus disease (B20) ; transplant failure and rejection (T86.-) ; underlying cause, such as: ; complications of transplanted organs and tissue (T86.-) ; complications of blood transfusion (T80.89) ; underlying cause, such as: ; complications following infusion, transfusion and therapeutic injection (T80.89-) ; complications of transplanted organs and tissue (T86.-)